Y. To et al., Early interleukin 4-dependent response can induce airway hyperreactivity before development of airway inflammation in a mouse model of asthma, LAB INV, 81(10), 2001, pp. 1385-1396
in experimental models of bronchial asthma with mice, airway inflammation a
nd increase in airway hyperreactivity (AHR) are induced by a combination of
systemic sensitization and airway challenge with allergens. In this report
, we present another possibility: that systemic antigen-specific sensitizat
ion alone can induce AHR before the development of inflammation in the airw
ay. Male BALB/c mice were sensitized with ovalbumin (OVA) by a combination
of intraperitoneal injection and aerosol inhalation, and various parameters
for airway inflammation and hyperreactivity were sequentially analyzed. Br
onchial response measured by a noninvasive method (enhanced pause) and the
eosinophil count and interleukin (IL)-5 concentration in bronchoalveolar la
vage fluid (BALF) gradually increased following the sensitization, and sign
ificant increase was achieved after repeated OVA aerosol inhalation along w
ith development of histologic changes of the airway. In contrast, AHR was a
lready significantly increased by systemic sensitization alone, although ai
rway inflammation hardly developed at that time point. BALF IL-4 concentrat
ion and the expression of IL-4 mRNA in the lung reached maximal values afte
r the systemic sensitization, then subsequently decreased. Treatment of mic
e with anti-IL-4 neutralizing antibody during systemic sensitization signif
icantly suppressed this early increase in AHR. In addition, IL-4 gene-targe
ted mice did not reveal this early increase in AHR by systemic sensitizatio
n. These results suggest that an immune response in the lung in an early st
age of sensitization can induce airway hyperreactivity before development o
f an eosinophilic airway inflammation in BALB/c mice and that IL-4 plays an
essential role in this process. If this early increase in AHR does occur i
n sensitized human infants, it could be another therapeutic target for earl
y prevention of the future onset of asthma.